Correlation Between Samsung Biologics and BitNine Co

Can any of the company-specific risk be diversified away by investing in both Samsung Biologics and BitNine Co at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Samsung Biologics and BitNine Co into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Samsung Biologics Co and BitNine Co, you can compare the effects of market volatilities on Samsung Biologics and BitNine Co and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Samsung Biologics with a short position of BitNine Co. Check out your portfolio center. Please also check ongoing floating volatility patterns of Samsung Biologics and BitNine Co.

Diversification Opportunities for Samsung Biologics and BitNine Co

-0.67

Correlation Coefficient

Samsung Biologics  BitNine Co

Excellent diversification

The 3 months correlation between Samsung and BitNine is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Samsung Biologics Co and BitNine Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BitNine Co and Samsung Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Samsung Biologics Co are associated (or correlated) with BitNine Co. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BitNine Co has no effect on the direction of Samsung Biologics i.e., Samsung Biologics and BitNine Co go up and down completely randomly.

Pair Corralation between Samsung Biologics and BitNine Co

Assuming the 90 days trading horizon Samsung Biologics Co is expected to under-perform the BitNine Co. But the stock apears to be less risky and, when comparing its historical volatility, Samsung Biologics Co is 7.74 times less risky than BitNine Co. The stock trades about -0.04 of its potential returns per unit of risk. The BitNine Co is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  179,643  in BitNine Co on September 28, 2024 and sell it today you would earn a total of  58,857  from holding BitNine Co or generate 32.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Samsung Biologics Co  vs.  BitNine Co

Samsung Biologics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Samsung Biologics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Samsung Biologics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

BitNine Co

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in BitNine Co are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, BitNine Co sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Samsung Biologics and BitNine Co

The main advantage of trading using opposite Samsung Biologics and BitNine Co positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Samsung Biologics position performs unexpectedly, BitNine Co can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BitNine Co will offset losses from the drop in BitNine Co's long position.

The idea behind Samsung Biologics Co and BitNine Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.